Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Blackstein

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II TrialR L Burkes, R J Ginsberg, F A Shepherd, et al.
Sarcoma|May 12, 2011
Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcomaH Al-Hussaini, D Hogg, M E Blackstein, et al.
Cancer Treatment Reports|November 1, 1981
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinomaW K Evans, R Feld, G DeBoer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study GroupI L Andrulis, S B Bull, M E Blackstein, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1992
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II TrialR L Burkes, R J Ginsberg, F A Shepherd, et al.
Sarcoma|May 12, 2011
Clinical features, treatment, and outcome in 102 adult and pediatric patients with localized high-grade synovial sarcomaH Al-Hussaini, D Hogg, M E Blackstein, et al.
Cancer Treatment Reports|November 1, 1981
Cyclophosphamide, doxorubicin, and cisplatin in the treatment of non-small cell bronchogenic carcinomaW K Evans, R Feld, G DeBoer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study GroupI L Andrulis, S B Bull, M E Blackstein, et al.
Pageof 3